Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report

Tacrolimus is an immunosuppressive drug used to prevent acute rejection following organ transplantation and to treat autoimmune disease. Tacrolimus is usually prescribed in such situation at a dose of 3.0 mg/day. Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC research notes 2013-12, Vol.6 (1), p.498-498, Article 498
Hauptverfasser:	Kato, Motoyasu, Tobino, Kazunori, Fujimoto, Yuichi, Kobayashi, Isao, Sugano, Koji, Tokuda, Hitoshi, Ienaga, Hiroki, Takahashi, Kazuhisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Arthritis, Rheumatoid - complications Autoimmune diseases Case Report Case studies Consent Consolidation Cytokines Dehydrogenases Disease Dosage and administration Dose-Response Relationship, Drug Drug dosages Drug therapy Drug therapy, Combination Family medical history Female Health aspects HIV Hospitals Human immunodeficiency virus Humans Inflammatory bowel disease Lymphocytes Medical treatment Medicine Methylprednisolone Methylprednisolone - administration & dosage Methylprednisolone - therapeutic use Mortality Patients Pneumocystis Pneumocystis carinii pneumonia Pneumonia, Pneumocystis - complications Pneumonia, Pneumocystis - drug therapy Polymerase chain reaction Proteins Pseudomonas Rheumatoid arthritis Steroids Surfactants Tacrolimus Tacrolimus - administration & dosage Tacrolimus - therapeutic use Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!